Omvoh (mirikizumab or mirikizumab-mrkz) helps treat ulcerative colitis and Crohn's disease in adults. It's a biologic known as an interleukin-23 antagonist. It works to help lower inflammation in the gut. When you first start, you'll get your first three doses as an infusion through the vein (IV) once a month at a clinic. After that, you (or your caregiver) can inject the rest of your doses under the skin every month at home. Side effects include joint pain and upper respiratory tract infections. Omvoh (mirikizumab) is available as a brand-name medication only.
Omvoh (mirikizumab) is a type of medication called an interleukin-23 antagonist. It blocks proteins called interleukin-23 (IL-23). These proteins play a key role in causing gut inflammation in people with ulcerative colitis and Crohn's disease.
By blocking IL-23, Omvoh (mirikizumab) helps lower inflammation in the gut. This can help improve symptoms like stomach pain, bloody stools, and diarrhea.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Induction with IV infusions
Maintenance with under-the-skin injections
Note: Side effects listed were reported by people with ulcerative colitis. They might slightly differ for people with Crohn's disease.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
What to expect for Omvoh (mirikizumab) IV infusions
How to use Omvoh (mirikizumab) at home
Yes, Omvoh is a biologic medication. Biologics are made from living things, like cells or proteins, in a lab. Omvoh is a type of monoclonal antibody, a protein that's made in cells in a lab setting. More specifically, it works by blocking interleukin-23. This helps lessen gut inflammation.
Omvoh is administered as an injection. For the first 3 doses, you'll get it through an infusion into the vein, also called an intravenous (IV) infusion. It's given by a healthcare professional at a clinic. After that, you switch to injections given under the skin of your stomach, thigh, or the back of your upper arm. Once your care team shows you how, you can give these injections at home by yourself.
Yes. The FDA first approved Omvoh for adults with ulcerative colitis in October 2023. Later in January 2025, the FDA approved the medication for adults with Crohn's disease . For both, Omvoh is a helpful option when other treatments haven't work well enough.
In studies, adults with ulcerative colitis who took Omvoh had fewer symptoms as early as 2 weeks. They had less rectal bleeding and less bathroom trips. But it could take a few months to see the full benefits of the medication. This timeline was similar for people with Crohn's disease. Keep in mind that everyone's experience with the medication is different. Be sure to keep taking Omvoh even if you don't feel better right away. Talk to your prescriber about how long it's taking for medication to help with your symptoms.
For ulcerative colitis, an Omvoh infusion takes at least 30 minutes. And for Crohn's disease, an infusion takes at least 90 minutes. Be sure to plan ahead for your infusion appointments. You can bring something to do to help pass the time. Examples include a book to read or an electronic device to watch your favorite show.
Omvoh and Skyrizi (risankizumab) are both injections that treat ulcerative colitis and Crohn's disease in adults. They work in similar ways and can both raise the risk of infections. Both start with 3 monthly doses given as an infusion through the vein once a month at a clinic. Then, you switch to under-the-skin injections at home. For Omvoh, these injections are given every month. But for Skyrizi, they're given every 2 months. Another difference is that Skyrizi is also approved for plaque psoriasis and psoriatic arthritis. Ask your prescriber to help compare to see which is best for you.
Omvoh and Stelara (ustekinumab) are both injections for adults with ulcerative colitis and Crohn's disease. But they have different dosing schedules. Omvoh starts with 3 monthly infusions given through the vein at a clinic. Then, you switch to monthly under-the-skin injections at home. For Stelara, it starts with just 1 infusion through the vein. Then 2 months later, you inject it under the skin at home every 2 months. Another difference is that Stelara can also help with plaque psoriasis and psoriatic arthritis in people 6 years and older. Ask your prescriber to compare the medications and help decide which is best for you.
If you're pregnant or thinking of getting pregnant, talk to your prescriber or obstetrician-gynecologist (OB-GYN) about taking Omvoh. There isn't enough information to know for sure how safe it is for you and your baby. But we know that having inflammatory bowel disease that isn't controlled during pregnancy can be harmful. Your care team can help you weight the risks and benefits. If you take Omvoh while pregnant, you can join the manufacturer's pregnancy registry. This program helps researchers learn more about how safe the medication is during pregnancy. Ask your prescriber or call Eli Lilly and Company at 1-800-545-5979 to find out more.
Omvoh (mirikizumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
It's possible to have an allergic reaction to Omvoh (mirikizumab). In studies, this sometimes happened during the IV infusions at the beginning of treatment.
The care team will watch for allergic reactions during your infusions. But call your care team or get medical help right away if you notice signs of anaphylaxis at any time. These include itching, skin redness, hives, trouble breathing, or swelling of the throat or face.
Omvoh (mirikizumab) can lower your body’s ability to fight off germs. This can put you at risk of getting an infection more easily. In studies, some people had upper respiratory tract infections or herpes viral infections.
Before starting Omvoh (mirikizumab), tell your prescriber about your medical history, including if you've had tuberculosis (TB). Your prescriber will weigh the risks and benefits to see if this medication is safe for you. If you have an infection, you'll need to wait until you're better to start Omvoh (mirikizumab). Your prescriber will also test you for TB before you begin. You might need treatment for any infections you already have.
Talk to a healthcare professional or call your prescriber if you have signs of an infection. Look out for fever, weakness, cough, sweating, chills, or an unexplained rash. If your care team thinks you have an infection, you might need to take a break from Omvoh (mirikizumab). You also might need to take antibiotics or other medications to treat the infection. This will help your body fight the infection better.
In studies, one person had liver injury after getting more than 3 induction doses of Omvoh (mirikizumab). After stopping the medication, their liver function went back to normal.
Although liver injury is rare at recommended doses, it’s important to be aware of this risk. Many people with high liver labs don’t feel physical symptoms, so blood work helps check that your liver is okay. Your prescriber will check your liver before you start Omvoh (mirikizumab). You’ll also need routine blood work for at least 6 months while taking the medication.
Call your care team and get medical help if you have signs of liver injury. Watch for signs like nausea, vomiting, stomach pain, yellowing of the skin or eyes, or dark urine. You might need to stop taking Omvoh (mirikizumab).
There isn't enough information to know how Omvoh (mirikizumab) affects how your body reacts to vaccines. To be safe, it's best to be up to date on all your vaccines before starting this medication.
Avoid live vaccines right before starting Omvoh (mirikizumab), during treatment, and right after your last injection. This medication can affect how well your immune system works. This can raise your risk of getting sick from a live vaccine itself. Examples include Varivax (chickenpox vaccine) and MMR (measles, mumps, and rubella vaccine).
Before getting any vaccines, tell your healthcare professional you’re taking Omvoh (mirikizumab). They can help make sure the vaccine is safe for you.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 2 pens of 100mg/ml | 1 carton | $5.00 | $5.00 |
| 1 1ml pen and 1 2ml pen of 200mg/2ml and 100mg/ml | 1 carton | $5.00 | $5.00 |
| 2 syringes of 100mg/ml | 2 cartons | $5.00 | $2.50 |
| 1 1ml syringe and 1 2ml syringe of 200mg/2ml and 100mg/ml | 1 carton | $5.00 | $5.00 |
| 1 pen of 200mg/2ml | 1 carton | $5.00 | $5.00 |
| 1 syringe of 200mg/2ml | 1 carton | $5.00 | $5.00 |
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 15ml of 300mg/15ml | 1 vial | $5.00 | $5.00 |
There are two phases of treatment: induction and maintenance. Omvoh (mirikizumab) has different dosing and administration for each phase.
Ulcerative colitis
Crohn's disease